Enzo Life Sciences, Inc.

Enzo Life Sciences, Inc. is a global leader in labeling and detection technologies for life sciences research and drug development. Founded in 1976 and headquartered in Farmingdale, New York, the company operates as a division of Enzo Biochem, Inc. Enzo Life Sciences specializes in developing and manufacturing technologies for genomic, protein, cell, and tissue analysis. The company offers a wide range of high-quality products, including antibodies, genomic probes, assays, biochemicals, and proteins. Enzo Life Sciences is recognized for its pioneering work in non-radioactive gene labeling technologies and has a robust portfolio supported by over 500 patents and more than 175,000 citations in scientific literature. Its products play a crucial role in translational research and drug development across various fields, including cancer research, immunology, and neuroscience. Enzo Life Sciences serves diverse customer segments, including biomedical and pharmaceutical research markets, clinical diagnostics, and academic institutions. The company is committed to being a scientific partner, providing expert support to meet the needs of its customers.